BHB-Phe, a newly discovered compound, reduces appetite and body weight by activating specific brain neurons. Researchers from ...

Today Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization announced a campaign to secure a recommendation for T1D screening from the United ...

Scientific breakthrough to prevent negative side effects of weight loss drugs like Ozempic - Millions across the world could ...

Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Good afternoon, and welcome to Fractyl Health’s Third Quarter Financial Results and Business Updates Call. As a reminder, this conference ...

New technologies and treatments revolutionizing diabetes care: Dr Ajay Aggarwal: Shardul Nautiyal, Mumbai Saturday, November 16, 2024, 08:00 Hrs [IST] As diabetes continues to ris ...

AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

Facility uses cutting-edge tech that changes how metabolic health is assessed and its impact on heart disease. Read more at ...

Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use in the U.S. in June 2024, in the E.U. in September ...

SeaStar Medical Holding Corporation (Nasdaq: ICU) ("SeaStar Medical" or the "Company"), a commercial-stage medical device company developing proprietary solutions ...

Topline results from registration-directed trial of ziftomenib in R/R NPM1-mutant AML expected in early 2025; Phase 1 results published in The Lancet Oncology – – Data from 100 patients in Phase 1a do ...

Alzheimer’s disease is the most common brain condition in older adults worldwide and a leading cause of dementia. Despite ...

FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...